Withaferin A as a Potential Anticancer Agent Targeting Hsp90/Cdc37 Complex
Author Information
Author(s): Grover Abhinav, Shandilya Ashutosh, Agrawal Vibhuti, Pratik Piyush, Bhasme Divya, Bisaria Virendra S, Sundar Durai
Primary Institution: Indian Institute of Technology (IIT) Delhi
Hypothesis
Can Withaferin A disrupt the Hsp90/Cdc37 chaperone/co-chaperone interactions to enhance tumor arresting activity?
Conclusion
Withaferin A is a potent anticancer agent that disrupts the stability of the Hsp90/Cdc37 complex, leading to enhanced tumor cell apoptosis.
Supporting Evidence
- The study demonstrated that Withaferin A can disrupt the Hsp90/Cdc37 complex, which is crucial for cancer cell survival.
- Molecular dynamics simulations showed that the binding of Withaferin A to the complex is thermodynamically stable.
- Withaferin A's ability to inhibit the association of Hsp90 with its co-chaperone Cdc37 was supported by significant binding energy values.
Takeaway
This study shows that a natural compound called Withaferin A can help fight cancer by stopping a protein complex that cancer cells need to grow.
Methodology
The study used molecular docking and molecular dynamics simulations to analyze the interaction between Withaferin A and the Hsp90/Cdc37 complex.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website